ZaÄtseva EA et al. |
[Comparative study of the antimicrobial activity of pefloxacin, ciprofloxacin, norfloxacin and azithromycin with respect to Strains of Yersinia pseudotuberculosis]. |
1996 |
Antibiot. Khimioter. |
pmid:8762820
|
Iakovlev SV and Ukhin SA |
[Azithromycin: general properties and regimen optimization based on pharmacokinetic and pharmacological parameters]. |
2003 |
Antibiot. Khimioter. |
pmid:12803047
|
Gomberg MA and MashkilleÄson AL |
[Use of azithromycin in long existing urogenital chlamydia infections and its association with primary syphilis]. |
1993 |
Antibiot. Khimioter. |
pmid:8060178
|
Skripkin IuK et al. |
[The problem of diagnosis and treatment of urogenital chlamydiosis in Russia]. |
1996 |
Antibiot. Khimioter. |
pmid:8929120
|
Vasil'ev MM and Gazarian IIu |
[Clinico-laboratory evaluation of the effectiveness of azithromycin in the treatment of patients with Chlamydia and mixed Chlamydia-gonorrhea infections]. |
1996 |
Antibiot. Khimioter. |
pmid:8929122
|
Sato T et al. |
In vitro intracellular activity and in vivo efficacy of modithromycin, a novel bicyclolide, against Legionella pneumophila. |
2011 |
Antimicrob. Agents Chemother. |
pmid:21220530
|
Waag DM |
Efficacy of postexposure therapy against glanders in mice. |
2015 |
Antimicrob. Agents Chemother. |
pmid:25645854
|
Seral C et al. |
Influence of P-glycoprotein inhibitors on accumulation of macrolides in J774 murine macrophages. |
2003 |
Antimicrob. Agents Chemother. |
pmid:12604540
|
Odenholt-Tornqvist I et al. |
Postantibiotic effects and postantibiotic sub-MIC effects of roxithromycin, clarithromycin, and azithromycin on respiratory tract pathogens. |
1995 |
Antimicrob. Agents Chemother. |
pmid:7695310
|
Roblin PM et al. |
In vitro activities of rifamycin derivatives ABI-1648 (Rifalazil, KRM-1648), ABI-1657, and ABI-1131 against Chlamydia trachomatis and recent clinical isolates of Chlamydia pneumoniae. |
2003 |
Antimicrob. Agents Chemother. |
pmid:12604555
|
Rodvold KA et al. |
Intrapulmonary steady-state concentrations of clarithromycin and azithromycin in healthy adult volunteers. |
1997 |
Antimicrob. Agents Chemother. |
pmid:9174209
|
Koeva M et al. |
An Antipersister Strategy for Treatment of Chronic Pseudomonas aeruginosa Infections. |
2017 |
Antimicrob. Agents Chemother. |
pmid:28923873
|
Nahata MC et al. |
Pharmacokinetics of azithromycin in pediatric patients after oral administration of multiple doses of suspension. |
1993 |
Antimicrob. Agents Chemother. |
pmid:8383944
|
Goldman RC et al. |
Role of protonated and neutral forms of macrolides in binding to ribosomes from gram-positive and gram-negative bacteria. |
1990 |
Antimicrob. Agents Chemother. |
pmid:2159256
|
Feola DJ et al. |
Azithromycin alters macrophage phenotype and pulmonary compartmentalization during lung infection with Pseudomonas. |
2010 |
Antimicrob. Agents Chemother. |
pmid:20231397
|
Riska PF et al. |
Genetic and culture-based approaches for detecting macrolide resistance in Chlamydia pneumoniae. |
2004 |
Antimicrob. Agents Chemother. |
pmid:15328134
|
Kutlin A et al. |
In vitro activities of azithromycin and ofloxacin against Chlamydia pneumoniae in a continuous-infection model. |
1999 |
Antimicrob. Agents Chemother. |
pmid:10471577
|
Bui KQ et al. |
Mononuclear and polymorphonuclear leukocyte dispositions of clarithromycin and azithromycin in AIDS patients requiring Mycobacterium avium complex prophylaxis. |
1999 |
Antimicrob. Agents Chemother. |
pmid:10471584
|
Zarantonelli L et al. |
Decreased azithromycin susceptibility of Neisseria gonorrhoeae due to mtrR mutations. |
1999 |
Antimicrob. Agents Chemother. |
pmid:10508026
|
Sugie M et al. |
Possible involvement of the drug transporters P glycoprotein and multidrug resistance-associated protein Mrp2 in disposition of azithromycin. |
2004 |
Antimicrob. Agents Chemother. |
pmid:14982769
|
Caceres SM et al. |
Enhanced in vitro formation and antibiotic resistance of nonattached Pseudomonas aeruginosa aggregates through incorporation of neutrophil products. |
2014 |
Antimicrob. Agents Chemother. |
pmid:25182651
|
den Hollander JG et al. |
Comparison of pharmacodynamics of azithromycin and erythromycin in vitro and in vivo. |
1998 |
Antimicrob. Agents Chemother. |
pmid:9527789
|
Hoffmann N et al. |
Azithromycin blocks quorum sensing and alginate polymer formation and increases the sensitivity to serum and stationary-growth-phase killing of Pseudomonas aeruginosa and attenuates chronic P. aeruginosa lung infection in Cftr(-/-) mice. |
2007 |
Antimicrob. Agents Chemother. |
pmid:17620382
|
Kohlhoff SA et al. |
In vitro activity of a novel diaminopyrimidine compound, iclaprim, against Chlamydia trachomatis and C. pneumoniae. |
2004 |
Antimicrob. Agents Chemother. |
pmid:15105151
|
Luke DR et al. |
Safety, toleration, and pharmacokinetics of intravenous azithromycin. |
1996 |
Antimicrob. Agents Chemother. |
pmid:8913468
|
Hogan PA and Sheehan DJ |
Macrolide susceptibility and beta-lactamase production among haemophilus influenzae isolates in the United States, 1996-1997. |
1998 |
Antimicrob. Agents Chemother. |
pmid:9835536
|
Geisler WM et al. |
Randomized, double-blind, multicenter safety and efficacy study of rifalazil compared with azithromycin for treatment of uncomplicated genital Chlamydia trachomatis infection in women. |
2014 |
Antimicrob. Agents Chemother. |
pmid:24798277
|
Mukherjee P et al. |
Emergence of high-level azithromycin resistance in Campylobacter jejuni isolates from pediatric diarrhea patients in Kolkata, India. |
2014 |
Antimicrob. Agents Chemother. |
pmid:24777098
|
Yoshioka D et al. |
Efficacy of β-Lactam-plus-Macrolide Combination Therapy in a Mouse Model of Lethal Pneumococcal Pneumonia. |
2016 |
Antimicrob. Agents Chemother. |
pmid:27480866
|
Jeong BH et al. |
Peak Plasma Concentration of Azithromycin and Treatment Responses in Mycobacterium avium Complex Lung Disease. |
2016 |
Antimicrob. Agents Chemother. |
pmid:27480854
|
Noedl H et al. |
In vitro antimalarial activity of azithromycin, artesunate, and quinine in combination and correlation with clinical outcome. |
2007 |
Antimicrob. Agents Chemother. |
pmid:17116669
|
Ednie LM et al. |
Comparative antianaerobic activities of the ketolides HMR 3647 (RU 66647) and HMR 3004 (RU 64004). |
1997 |
Antimicrob. Agents Chemother. |
pmid:9303406
|
Roblin PM et al. |
In vitro activity of trovafloxacin against Chlamydia pneumoniae. |
1997 |
Antimicrob. Agents Chemother. |
pmid:9303410
|
Frank MO et al. |
In vitro demonstration of transport and delivery of antibiotics by polymorphonuclear leukocytes. |
1992 |
Antimicrob. Agents Chemother. |
pmid:1336337
|
O'Reilly T et al. |
Relationship between antibiotic concentration in bone and efficacy of treatment of staphylococcal osteomyelitis in rats: azithromycin compared with clindamycin and rifampin. |
1992 |
Antimicrob. Agents Chemother. |
pmid:1336342
|
Taylor WR et al. |
Tolerability of azithromycin as malaria prophylaxis in adults in northeast papua, indonesia. |
2003 |
Antimicrob. Agents Chemother. |
pmid:12821468
|
Seral C et al. |
Quantitative analysis of gentamicin, azithromycin, telithromycin, ciprofloxacin, moxifloxacin, and oritavancin (LY333328) activities against intracellular Staphylococcus aureus in mouse J774 macrophages. |
2003 |
Antimicrob. Agents Chemother. |
pmid:12821480
|
Ravdin JI and Skilogiannis J |
In vitro susceptibilities of Entamoeba histolytica to azithromycin, CP-63,956, erythromycin, and metronidazole. |
1989 |
Antimicrob. Agents Chemother. |
pmid:2548442
|
Bermudez LE and Young LS |
Activities of amikacin, roxithromycin, and azithromycin alone or in combination with tumor necrosis factor against Mycobacterium avium complex. |
1988 |
Antimicrob. Agents Chemother. |
pmid:2847644
|
Salman S et al. |
Pharmacokinetics of Transfer of Azithromycin into the Breast Milk of African Mothers. |
2015 |
Antimicrob. Agents Chemother. |
pmid:26711756
|
Viscardi RM et al. |
Azithromycin to prevent bronchopulmonary dysplasia in ureaplasma-infected preterm infants: pharmacokinetics, safety, microbial response, and clinical outcomes with a 20-milligram-per-kilogram single intravenous dose. |
2013 |
Antimicrob. Agents Chemother. |
pmid:23439637
|
Cynamon MH et al. |
Comparative activities of azithromycin and clarithromycin against Mycobacterium avium infection in beige mice. |
1994 |
Antimicrob. Agents Chemother. |
pmid:7979270
|
Ressner RA et al. |
Antimicrobial susceptibilities of geographically diverse clinical human isolates of Leptospira. |
2008 |
Antimicrob. Agents Chemother. |
pmid:18411316
|
Pankuch GA et al. |
In vitro selection of resistance to four beta-lactams and azithromycin in Streptococcus pneumoniae. |
1998 |
Antimicrob. Agents Chemother. |
pmid:9797225
|
Bergman M et al. |
Macrolide and azithromycin use are linked to increased macrolide resistance in Streptococcus pneumoniae. |
2006 |
Antimicrob. Agents Chemother. |
pmid:16940064
|
Gladue RP et al. |
In vitro and in vivo uptake of azithromycin (CP-62,993) by phagocytic cells: possible mechanism of delivery and release at sites of infection. |
1989 |
Antimicrob. Agents Chemother. |
pmid:2543276
|
Araujo FG et al. |
Azithromycin, a macrolide antibiotic with potent activity against Toxoplasma gondii. |
1988 |
Antimicrob. Agents Chemother. |
pmid:2840017
|
Pereira MR et al. |
In vivo and in vitro antimalarial properties of azithromycin-chloroquine combinations that include the resistance reversal agent amlodipine. |
2011 |
Antimicrob. Agents Chemother. |
pmid:21464242
|
Garey KW et al. |
Lack of effect of zafirlukast on the pharmacokinetics of azithromycin, clarithromycin, and 14-hydroxyclarithromycin in healthy volunteers. |
1999 |
Antimicrob. Agents Chemother. |
pmid:10223928
|
Jang MO et al. |
Outcome of intravenous azithromycin therapy in patients with complicated scrub typhus compared with that of doxycycline therapy using propensity-matched analysis. |
2014 |
Antimicrob. Agents Chemother. |
pmid:24366734
|